Kodiak Sciences

World Rank (Jan-05-2024)

19,085

Market Cap (Jan-05-2024)

0.160 Billion USD

World Rank (Jul-30-2023)

19,561

Market Cap (Jul-30-2023)

0.150 Billion USD

World Rank (Jan-07-2022)

4,108

Market Cap (Jan-07-2022)

3.735 Billion USD

World Rank (Jan-01-2021)

2,135

Market Cap (Jan-01-2021)

7.459 Billion USD

Headquarters Country

USA

Nasdaq / NYSE Code

KOD

Market Cap (Mar-08-2026)

1.49

Employee Count

85

Employee Count as of Date

As on Sep-2021

Headquarters City/State

California

World Region

Americas

World Subregion

Northern America

Annual Revenue in USD

0 Million USD

Annual Net Income in USD

-266 Million USD

Annual Results for Period Ending

Dec-2021 ending year

Total Assets in USD

904 Million USD

Total Liabilities in USD

240 Million USD

Total Equity in USD

663 Million USD

Balance Sheet for Period Ending

Dec-2021 ending year

Business Sector

Company Website

Yahoo

Company Profile

Kodiak Sciences is a Clinical Stage Biopharmaceutical company. It is specializing in novel therapeutics to treat chronic and high prevalence ophthalmic diseases. The headquarters is in USA.

Annual Results Summary

KODIAK SCIENCES - Yearly Revenue and Net Income - in Million USD:

Year - Ending	Revenue	Operating Income	Net Income
Dec-2021	0	-267 (Loss)	-266 (Loss)
Dec-2020	0	-136 (Loss)	-133 (Loss)
Dec-2019	0	-49 (Loss)	-47 (Loss)
Dec-2018	0	-26 (Loss)	-41 (Loss)